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Abstract
γδ T cells commonly associate with mucosal and epithelial sites, fulﬁlling a variety
of immunoregulatory functions. While lung γδ T cells have well-characterized pro-
inﬂammatory activity, their potential role in the resolution of lung inﬂammation has yet
to be explored in any detail. Indeed, given the importance of minimizing inﬂammation,
the cellular mechanisms driving the resolution of lung inﬂammation are poorly understood.
Using a murine model of acute Streptococcus pneumoniae-mediated lung inﬂammation, we
now show that resolution of inﬂammation following bacterial clearance is associated with
a >30-fold increase in γδ T-cell number. Although inﬂammation eventually resolves in
TCRδ−/− mice, elevated numbers of alveolar macrophages and pulmonary dendritic cells,
and the appearance of well-formed granulomas in lungs of TCRδ−/− mice, together indicated
a role for γδ T cells in regulating mononuclear phagocyte number. Ex vivo, both alveolar
macrophages and pulmonary dendritic cells were susceptible to lung γδ T cell-mediated
cytotoxicity, the ﬁrst demonstration of such activity against a dendritic cell population.
These ﬁndings support a model whereby expansion of γδT cells helps restore mononuclear
phagocyte numbers to homeostatic levels, protecting the lung from the consequences of
inappropriate inﬂammation.
Copyright  2007 Pathological Society of Great Britain and Ireland. Published by John
Wiley & Sons, Ltd.
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Introduction
Appropriate regulation and resolution of acute pul-
monary inﬂammatory responses are critical for main-
tenance of tissue integrity, avoidance of host-mediated
pathology, and host survival. Lung inﬂammation fol-
lowing pneumococcal infection involves extensive
inﬂammatory cell inﬂux into tissues and alveolar
spaces, perivascular oedema, and substantial consol-
idation [1,2]. Nevertheless, following bacterial clear-
ance, inﬂammation rapidly resolves, leaving little
structural or morphological evidence to indicate that
the response occurred [2,3]. However, the mechanisms
involved in resolving inﬂammation are not currently
well understood.
A major cell population involved in regulating
pulmonary innate immune responses is the alveolar
macrophage (AM). AMs control the threshold at
which innate responses to streptococcal infection are
initiated [4] and are involved in resolution of acute
pulmonary inﬂammation through phagocytic clearance
of apoptotic neutrophils [5–7]. Moreover, apoptotic
AMs may reduce inﬂammatory responses and are
themselves cleared by AMs [8]. While the inﬂux of
new AMs continues after bacterial clearance [9], most
likely to remove inﬂammatory ‘debris’, the question of
how AMs are themselves regulated during resolution
remains open.
A recently described mechanism for control of
macrophage responses is through the direct action of
γδ T cells [10,11]. Killing of activated macrophages
by γδ T cells prevents excessive inﬂammatory res-
ponses and necrotic liver damage following Listeria
infection [12], and restricts parasite growth and host-
mediated pathology in Toxoplasma gondii infection
[11]. Finally, lung γδT cells isolated from Mycobac-
terium bovis BCG-infected mice are cytotoxic against
infected peritoneal macrophages [13]. However, γδT
cells are a rare population in most tissues [14] and
the extent to which γδ T cells mediate resolution
of inﬂammation following pathogen clearance remains
unclear.
While a role for γδ T cells in Streptococcus pneu-
moniae infection has not previously been described,
γδ T cells have various immunoregulatory functions
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in other pulmonary inﬂammation models. γδ T-cell
responses appear to be responsible for appropriate
cytokine responses to inﬂuenza [15,16] and Kleb-
siella pneumoniae [17]; may inﬂuence the inﬂux
of inﬂammatory cells to control Nocardia asteroides
infection [18,19]; and contribute to IFNγ [13] and IL-
17 [20] production following mycobacterial challenge.
In contrast, γδ T cells may inhibit pro-inﬂammatory
responses to Cryptococcus neoformans, possibly pre-
venting excessive Th1 responses [21]. However, in
none of these models has the role of γδT cells during
the resolution phase of the response been examined.
We have previously described a model of
S. pneumoniae-induced lung inﬂammation in which
an acute, phagocyte-dominated inﬂammatory response
results in pathogen clearance within 5 days [2].
Intranasal (i.n.) challenge with S. pneumoniae serotype
6B induces inﬂammation which results in substan-
tial modulation of AM and pulmonary dendritic
cell (pulDC) populations which extends well beyond
pathogen clearance. Here we demonstrate that the res-
olution phase of S. pneumoniae-induced pulmonary
inﬂammation is accompanied by a more than 30-fold
increase in lung γδT-cell number. Nevertheless, these
cells do not contribute to bacterial clearance, but are
directly cytotoxic against AMs and pulDCs. Together
with the appearance of small coherent granulomas in
TCRδ−/− mice, these studies suggest that cytotoxic γδ
T cells play an important role in regulating the expan-
sion and homeostatic control of these inﬂammatory
cell populations.
Materials and methods
Mice and pneumococcal infection
C57BL/6 and B6.TCRδ−/− mice were bred and
housed under barrier conditions at LSHTM and the
University of York, and supplied with food and water
ad libitum. Mice were infected i.n. with 108–109 cfu
of a clinical isolate of S. pneumoniae serotype 6B
(Microbiology Department, Royal Free Hospital) as
previously described [2,9]. Animal experimentation
was performed with LSHTM and University of York
Animal Procedures Ethics Committee and UK Home
Ofﬁce approval.
Tissue preparation
Recovery of bronchoalveolar lavage ﬂuid (BALF) and
preparation of whole lungs (no BALF harvest) were
performed as previously described [2,9]. Viable cell
counts were determined by trypan blue exclusion. Tis-
sue sections were prepared and imaged as previously
described [9].
Flow cytometry and cell sorting
Flow cytometry was carried out using the fol-
lowing clones and reagents (all BD Pharmingen):
GL3 (TCRδ); 145.2C11 (CD3); H57-597 (TCR β);
GK1.5 (CD4);, 53-6.7 (CD8α); RA3.6B2 (B220);
HL3 (CD11c); 2G9 (MHC-II); and M1/70 (CD11b),
together with appropriate isotype controls. All sam-
ples were treated with anti-FcγRII/III (2.4G2) prior
to speciﬁc staining. Samples were acquired on a
FACSCalibur ﬂow cytometer and analysed with Cel-
lQuest Pro software (both Becton Dickinson Oxford,
UK), or on a Cyan ﬂow cytometer and analysed with
Summit v4.1 software (both DakoCytomation).
CD11c+ AMs and pulDCs were sorted from whole
lung cell preparations following MACS (Miltenyi
Biotech, Germany) enrichment [9] using a MoFlo cell
sorter (DakoCytomation). CD3+ T-cell populations
from whole lung cells or CD11c-depleted lung cells
were enriched by MACS. Depletion of αβ T cells from
enriched CD3+ cells was also performed by MACS.
Cytotoxic assay
Cytotoxic activity of CD3+ cells, or CD3+ cells
depleted of αβ+ T cells, was assessed using a
Live/Dead cell-mediated cytotoxicity kit (Molecular
Probes) according to the manufacturer’s instructions
and established protocols [10]. Brieﬂy, sorted, DiOC-
labelled AMs or pulDCs (1 × 105 per well) were used
as targets in triplicate cultures incubated with unla-
belled effector cells in the presence of propidium
iodide (PI) for 4 h at 37 ◦C. Killing was assessed by
ﬂow cytometry, with dead targets being DiOC+PI+.
Speciﬁc killing was determined in comparison with
wells containing targets only. F(ab)2 fragments of
GL3 (anti-TCRδ) or control antibody were included
at 10 µg/ml in some assays.
Results
Pulmonary γδT-cell accumulation associates with
resolution of inﬂammation
Intranasal (i.n.) challenge with non-lethal S. pneumo-
niae serotype 6B induces a rapid, transient neutrophil-
dominated phagocyte response; bacterial clearance by
day 5; and a resolution phase extending to more than
14 days post-challenge [2]. Early pathological fea-
tures are typical of pneumonia, with inﬂammatory cell
migration into alveoli resulting in extensive consolida-
tion (Figures 1a and 1b). Nevertheless, this consolida-
tion rapidly resolves after the initial pathogen insult is
cleared, with only small inﬂammatory foci remaining
by day 7 (Figure 1c). By 14 days, the challenged lung
is largely histopathologically indistinguishable from
that of unchallenged mice (Figure 1d).
Since CD4+ [22] and CD8+αβ T cells [23], as well
as γδ T cells [24], have been ascribed immunoreg-
ulatory properties in the inﬂamed lung, we investi-
gated whether these populations were involved in the
rapid restoration of consolidated lung tissue back to
an uninﬂamed state. Therefore, lung lymphocyte pop-
ulations were analysed during the initiation and reso-
lution phases of S. pneumoniae-induced inﬂammation.
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Figure 1. Inﬂammation and resolution within lung tissue following S. pneumoniae serotype 6B challenge. Haematoxylin and eosin
staining of lung sections from (a, e) na¨ ı v em i c eo rf r o mm i c ea t( b ,f )3d a y s ,( c ,g )7d a y s ,a n d( d ,h )1 4d a y sp o s t - S. pneumoniae
challenge (n = 6–12 at each time point). Original magniﬁcations: (a–d) ×100; (e–h) ×400. The boxes in a–d indicate the area of
image presented at higher magniﬁcation
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Signiﬁcant but slight (less than two-fold) changes in
the numbers of pulmonary CD4+ or CD8+ T cells,
B cells or NK cells were observed over the 14 days
following challenge (data not shown). In contrast,
absolute numbers of γδT cells in the lung following S.
pneumoniae challenge were increased more than 30-
fold at the peak of the response (days 7–10; Figure 2).
In na¨ ıve animals, CD3+TCRβ−TCRγδ+γδ T cells
(Figure 2a) comprised 3.03 ± 1.2 × 104 cells per lung
(Figure 2b), in agreement with recent estimates [25].
While this number was signiﬁcantly increased as early
as day 3 post-S. pneumoniae challenge (p < 0.05),
the response peaked at days 7–10 (Figure 2b), despite
there being no detectable bacteria in the lung later
than day 5 post-challenge (refs 2 and 9 and data
not shown). Increased γδ T-cell populations were
strikingly restricted to the lung, with less than two-fold
Figure 2. γδT-cell number in the lung following pneumococcal
challenge. (a) Gated CD3
+ lung cells were compared for
expression of TCRδ and TCRβ at day 0 (na¨ ıve) and day 7
following S. pneumoniae challenge. Numbers represent TCRδ+
cells as a percentage of CD3
+ cells and of total lung cells
(in parentheses). Data are representative of at least 12 mice.
(b) The absolute number of γδ T cells in the total lung and
(c) the % γδT cells within BALF at the indicated times following
S. pneumoniae challenge are shown. Graph points represent
mean (±1S D ) .A l lg r a p h sr e p r e s e n t6 – 1 8m i c ea te a c ht i m e
point. ∗p < 0.05 versus na¨ ıve control, by Student’s t-test
changes in the proportions of γδ T cells observed in
draining lymph nodes, blood, and spleen of infected
mice (data not shown).
S. pneumoniae challenge results in large numbers of
inﬂammatory cells entering alveoli (Figure 1b) [26].
We examined BALF from na¨ ıve and S. pneumoniae-
challenged mice to determine whether γδ T cells
access this compartment. Although BALF from na¨ ıve
mice contained few lymphocytes, a low percent-
age expressed the γδ TCR (0.7 ± 0.2%, Figure 2c).
Following pneumococcal challenge, TCRγδ+ cells
increased in BALF in correlation with their increase
in total lung, comprising 23.8 ± 1.2% of BALF cells
at day 10 (Figure 2c). Thus, S. pneumoniae challenge
induces a strong pulmonary γδ T-cell response, with
cells entering alveolar spaces as well as lung tissue.
Notably, the peak γδT-cell response occurs after bac-
terial clearance.
AM and pulDC responses are dysregulated in the
absence of γδT cells
In wild-type mice, signiﬁcant characteristics of the
resolution phase following clearance of S. pneumoniae
serotype 6B are the changes which occur within
AM and pulDC populations [2,9]. Therefore, AMs
and pulDCs were examined in wild-type and γδ T-
cell-deﬁcient (TCRδ−/−) mice at days 7–14 post-
challenge, covering the peak of the γδT-cell response
during resolution. TCRδ−/− mice given S. pneumoniae
serotype 6B did not succumb to infection and no
bacteria were recovered from the lungs of TCRδ−/−
mice at days 7–14 post-challenge (n = 24).
AMs and pulDCs were identiﬁed in parallel
based on differential expression of CD11c, MHCII,
CD11b, and on size, granularity, and autoﬂuores-
cence [9]. Na¨ ıve wild-type and TCRδ−/− mice
had qualitatively and quantitatively comparable pop-
ulations of CD11cHIMHCIIINTCD11bLO AMs and
CD11cHIMHCIIHICD11b+/− pulDCs (Figure 3a, left
panels). S. pneumoniae challenge of wild-type mice
induced phenotypic and quantitative changes in both
populations, including the appearance of CD11bHI
AMs [9] (Figure 3a, upper panels). At day 7 post-
challenge, both AMs (p < 0.001) and pulDCs (p <
0.001) were signiﬁcantly elevated in number compared
with na¨ ıve controls. Both AM and pulDC numbers
remained elevated at day 14 post-challenge, although
pulDCs were signiﬁcantly reduced in number com-
pared with day 7 (p = 0.002; Figure 3c).
Analysis of TCRδ−/− mice revealed exaggerated
AM and pulDC responses, with consistent increases
in CD11b+ cells compared with wild-type controls
(Figure 3a). In TCRδ−/− mice, AMs were two-
fold more abundant than in wild-type mice at day
7 post-challenge (p < 0.001) and remained signiﬁ-
cantly above control numbers at day 14 (p < 0.001;
Figure 3b). Notably, CD11bHI, newly inﬂuxed AMs
[9] were signiﬁcantly increased in TCRδ−/− mice
both at day 7 (Figure 3a and data not shown; mean
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Figure 3. Dysregulation of AM and pulDC responses in TCRδ−/− mice. Total lung cells from na¨ ive mice, or mice challenged with
S. pneumoniae, were analysed for AMs and pulDCs. (a) Gated CD11c
+ lung cells in wild-type (upper plots) and TCRδ−/− (lower
plots) mice analysed for expression of MHCII (x-axis) and CD11b (y-axis). R1 deﬁnes AMs and R2 deﬁnes pulDCs in na¨ ive mice.
During infection, additional ﬂow cytometric parameters are used to conclusively identify AMs and pulDCs, as described elsewhere
[9]. (b) Absolute numbers of AMs and (c) pulDCs in the lungs of wild-type and TCRδ−/− mice before and following S. pneumoniae
challenge (n = 6 or more at each time point). Bars represent mean (±1S D ) .∗p < 0.05 versus wild-type control at the same time
point, by Student’s t-test
8.5 ± 2.6 × 105) compared with wild-type mice (4.1 ±
2.0 × 105; p < 0.01) and at day 14 (6.5 ± 1.6 × 105
versus 4.1 ± 0.5 × 105; p < 0.0001).
Similarly, pulDC responses in TCRδ−/− mice
were signiﬁcantly increased, being more than three-
fold more abundant than controls at day 7 (p <
0.001), remaining elevated at day 14 (p = 0.02;
Figure 3c). In contrast to AMs, inﬂuxing pulDCs
in both TCRδ−/− and control mice were predomi-
nantly CD11bHI (Figure 3a) [9]. These data suggest
γδ T-cell involvement in regulating AM and pulDC
numbers during resolution of S. pneumoniae-mediated
inﬂammation.
γδT cells kill both AMs and pulDCs
Since activated splenic and peritoneal macrophages are
susceptible to TCRδ-dependent, γδ T-cell-mediated
killing [10–12], we examined whether γδ T cells
might exert cytotoxic activity against AMs and pulDCs
following pneumococcal challenge. Puriﬁed (>95%)
AMs or pulDCs were co-cultured with MACS-puriﬁed
CD3+ cells from CD11c+-depleted day 7 post-
challenge lung cell suspensions, of which 25–40%
were TCRδ+ cells. Lung populations depleted of αβ
T cells were also used, in which effector CD3+ cells
were more than 95% TCRγδ+.
CD3+ effector cells caused dose-dependent death
of AMs taken from lungs at day 7 post-challenge
(Figure 4a), as did αβ T-cell-depleted, enriched γδ
T cells (Figure 4b). Both total CD3+ and αβ T-
cell-depleted effector cells were also efﬁcient in
killing pulDCs from mice at day 7 post-challenge
(Figures 4c and 4d). Furthermore, inclusion of block-
ing antibody against TCRδ, but not control anti-
body, reduced pulDC killing by CD3+ effectors
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Figure 4. γδT cells are cytotoxic for AMs and pulDCs. Enriched lung T cells from day 7 following S. pneumoniae challenge were
used in various ratios as effectors against DiOC-labelled AM (a, b) and (c, d) pulDC targets in a cytotoxic assay. The percentage
of dead targets, identiﬁed as DiOC
+PI
+ cells, is shown. Total CD3
+ (a, c) or TCRβ-depleted CD3
+ (b, d) cells used as effectors
against labelled targets from na¨ ive ()o ri n f e c t e d( ) mice. At least 10000 DiOC
+ target cells were analysed in each case. Plots
are representative of four separate experiments
at a 3:1 effector:target ratio by 52 ± 4% (p =
0.019).
Previous studies demonstrated that only activated
peritoneal macrophages were effectively killed by γδ
T cells [10]. We examined whether AMs and pulDCs
from na¨ ıve mice could act as targets for γδ T cells.
Both CD3+ and γδT-cell-enriched effectors from day
7 lungs killed na¨ ıve AMs, although less efﬁciently than
AMs from S. pneumoniae-challenged mice (Figures 4a
and 4b). Surprisingly, na¨ ıve pulDCs were equally sus-
ceptible to killing, as were those pulDCs from chal-
lenged hosts (Figures 4c and 4d). These data represent
the ﬁrst observation of γδ T-cell-mediated killing of
a dendritic cell population.
γδT-cell deﬁciency results in granuloma
development during resolution of
S. pneumoniae-induced inﬂammation
To examine whether dysregulation of AMs and
pulDCs affected the histopathological features of the
resolving lung, we examined wild-type and TCRδ−/−
mice at day 5 post-challenge. At this stage, while
resolution is under way, signiﬁcant areas of inﬂam-
mation remain for histological evaluation.
Wild-type lungs at day 5 following pneumococcal
challenge showed relatively small areas of predomi-
nantly perivascular inﬂammation remaining through-
out the tissue (Figure 5a). In TCRδ−/− mice, perivas-
cular inﬂammation was also apparent at day 5. How-
ever, TCRδ−/− lungs also exhibited small granulo-
mas within inﬂammatory foci (Figures 5b and 5c). A
total of 27 granulomas were present in 48 inﬂam-
matory foci at day 5 in the TCRδ−/− group (n =
4), compared with no granulomas from 76 foci in
the control group (n = 4). No other differences in
histopathological features were apparent between the
groups. In both wild-type and TCRδ−/− mice, all
coherent inﬂammatory foci and any associated granu-
lomas had resolved by day 14 post-challenge (data not
shown).
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Figure 5. Altered histopathological features during resolution
in TCRδ−/− mice. Haematoxylin and eosin-stained sections
of lung tissue from (a) wild-type and (b, c) TCRδ−/− mice
challenged 5 days previously with S. pneumoniae 6B. Original
magniﬁcation: (a, b) ×400; (c) ×1000
Discussion
The present study uses a model of pneumococcal chal-
lenge to examine possible mechanisms underlying the
resolution of inﬂammation following pathogen clear-
ance. S. pneumoniae challenge induces a substantial
γδ T-cell response which does not appear to con-
tribute to antibacterial activity. γδ T cells may most
commonly facilitate effective responses to pulmonary
and non-pulmonary pathogens [17–19,21,26,27], and
absence of γδ T cells may profoundly inﬂuence host
survival [19]. In contrast, TCRδ−/− mice have no deﬁ-
ciency in clearance of S. pneumoniae and the γδT-cell
response peaks after bacterial clearance, reﬂecting ear-
lier studies of viral lung infections [15,28]. Ongoing
studies indicate that multiple γδT-cell subsets, includ-
ing the Vγ1 and Vγ4 subsets recently observed in
na¨ ıve lung [25], are involved following pneumococ-
cal challenge (Kirby et al, unpublished data). While
both Vγ1 and Vγ4 subsets are also involved in early
responses to mycobacteria [13], whether γδ T-cell
subsets have differential functions during bacterial
lung infections remains to be deﬁned.
Absence of γδT cells results in striking quantitative
increases in AMs and pulDCs during resolution of S.
pneumoniae-induced inﬂammation, including notably
elevated numbers of CD11bHI AMs. CD11b expres-
sion is required for AM inﬂux following pneumococ-
cal challenge [9], suggesting that γδT-cell deﬁciency
leads to excessive accumulation of newly recruited
AMs. In the wild-type host, γδ T cells may down-
regulate local production of inﬂammatory mediators,
limiting AM and pulDC recruitment. However, our
data strongly suggest that γδT-cell regulatory activity
is exerted via direct cytotoxicity. In other lung infec-
tion models, γδT-cell cytotoxicity is not a consistent
phenotype. While γδT cells from early M.bovis infec-
tion were cytotoxic [13], those from inﬂuenza-infected
mice lacked cytotoxic activity [29]. These differences
may reﬂect the functional heterogeneity of γδ T-cell
populations and their ability to respond to differing
inﬂammatory environments [30]. Importantly, how-
ever, rather than contributing to pathogen clearance,
as in T. gondii [11] and M. bovis [13] infections,
γδ T-cell cytotoxicity in the current model is clearly
resolution-associated.
Strikingly, pulDCs as well as AMs are suscepti-
ble to lung γδ T-cell-mediated cytotoxicity. This is
the ﬁrst demonstration that γδ T cells can kill not
only macrophages, but also dendritic cells. While Fas
expression, involved in γδ T-cell killing of splenic
macrophages [31], is increased on pulDCs, but not
AMs, following pneumococcal challenge (our unpub-
lished observations), the speciﬁc mechanism of pulDC
killing remains under investigation. The role of pul-
monary Vγ1+ cells [25], central to this process in both
Listeria [10,32] and Toxoplasma gondii [11] infec-
tions, also remains undetermined.
Isolated γδ T cells have previously only been
shown to kill activated, but not na¨ ıve, macrophages
[10,13]. Lung γδ T cells recovered 7 days after S.
pneumoniae challenge killed both na¨ ıve and infected
AMs and pulDCs. While this suggests a role for
γδ T cells in regulating these populations during
homeostasis, na¨ ıve lungs contain only approximately
3 × 104γδT cells, and no difference in AM or pulDC
number was apparent between unchallenged wild-type
and TCRδ−/− mice. Although this does not formally
exclude a role for γδT cells in homeostatic regulation
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of AMs and pulDCs, such a function is considered
unlikely. Perhaps of more interest for future study, our
data suggest that both AMs and pulDCs constitutively
express ligands able to direct γδ T-cell killing.
That AM and pulDC numbers eventually decline in
TCRδ−/− mice may suggest a non-essential contribu-
tion of γδ T cells during late resolution. However,
this observation also emphasizes the extent of γδ T-
cell-mediated control of AM and pulDC populations
observed over days 7–14. In the current model, the
progressive reduction in AMs and pulDCs in TCRδ−/−
mice likely reﬂects general reductions in inﬂammatory
stimuli in the absence of pathogen load post-day 5. The
γδT-cell-mediated reduction of pulDC numbers once
antigen load is signiﬁcantly reduced (days 3–5) may
restrict inappropriate antigen presentation and inﬂam-
matory mediator production. In contrast, AM recruit-
ment following bacterial clearance [9] is required for
the removal of cellular debris [7]. Therefore, even in
the presence of γδT cells, the return of AM numbers
to pre-challenge levels takes substantially longer than
for pulDCs.
Excessive numbers of activated macrophages are not
beneﬁcial to the host [11,12,33]. This study strongly
indicates that γδ T cells control AM numbers dur-
ing resolution of lung inﬂammation. Since γδ T cells
kill activated tissue macrophages [10], it is possible
that they also act against lung tissue macrophages in
the current model. That TCRδ−/− mice exhibit small
granulomas within inﬂammatory foci is suggestive of
such activity, although this has not been directly exam-
ined. Alternatively, granuloma formation may occur
due to dysregulated AM and pulDC activity. Stud-
ies using mycobacterial infections have demonstrated
γδ T-cell association with granulomas and inﬂuence
upon their formation [34,35]. γδ T cells may, there-
fore, help to determine the correct cellular composition
of granulomas associated with bacterial infection. In
the current model, spontaneous resolution of granulo-
mas by day 14 most likely reﬂects the transient nature
of pneumococcal-induced inﬂammation, as described
above. However, in chronic disease, where inﬂamma-
tory stimuli or pathogen load persist, γδ T cells may
play a major role in regulating pathological features
such as granulomas.
Together, the current data enhance the immunoreg-
ulatory reputation of γδ T cells and suggest that
γδ T-cell-mediated cytotoxicity against inﬂammatory
populations may be widespread during resolution of
inﬂammation.
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